{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:26:12Z","timestamp":1793384772407,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007732","name":"American Macular Degeneration Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["Catalyst Award"],"award-info":[{"award-number":["Catalyst Award"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["EY027691"],"award-info":[{"award-number":["EY027691"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wilmer-Bayer Alliance Grant, Bayer Pharmaceuticals, Inc"},{"DOI":"10.13039\/100001694","name":"International Retinal Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Age-related macular degeneration (AMD) is the most common cause of blindness among the elderly in the developed world. While treatment is effective for the neovascular or \u201cwet\u201d form of AMD, no therapy is successful for the non-neovascular or \u201cdry\u201d form. Here we discuss the current knowledge on dry AMD pathobiology and propose future research directions that would expedite the development of new treatments. In our view, these should emphasize system biology approaches that integrate omic, pharmacological, and clinical data into mathematical models that can predict disease onset and progression, identify biomarkers, establish disease causing mechanisms, and monitor response to therapy.<\/jats:p>","DOI":"10.1038\/s41467-019-11262-1","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T06:03:04Z","timestamp":1564120984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":284,"title":["A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration"],"prefix":"10.1038","volume":"10","author":[{"given":"James T.","family":"Handa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Bowes Rickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-7982","authenticated-orcid":false,"given":"Michael B.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2046-3996","authenticated-orcid":false,"given":"Joan W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ueffing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zarbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Farrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"11262_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob. Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Glob. Health"},{"key":"11262_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40662-016-0063-5","volume":"3","author":"KL Pennington","year":"2016","unstructured":"Pennington, K. L. & DeAngelis, M. M. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis. (Lond.) 3, 34 (2016).","journal-title":"Eye Vis. (Lond.)"},{"key":"11262_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/jamaophthalmol.2013.6636","volume":"132","author":"EY Chew","year":"2014","unstructured":"Chew, E. Y. et al. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36. JAMA Ophthalmol. 132, 272\u2013277 (2014).","journal-title":"JAMA Ophthalmol."},{"key":"11262_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld, P. J. et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355, 1419\u20131431 (2006).","journal-title":"N. Engl. J. Med."},{"key":"11262_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Age-Related Eye Disease Study Research, G.","year":"2001","unstructured":"Age-Related Eye Disease Study Research, G. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch. Ophthalmol. 119, 1417\u20131436 (2001).","journal-title":"Arch. Ophthalmol."},{"key":"11262_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","author":"Age-Related Eye Disease Study 2 Research Group.","year":"2013","unstructured":"Age-Related Eye Disease Study 2 Research Group. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309, 2005\u20132015 (2013).","journal-title":"JAMA"},{"key":"11262_CR7","first-page":"1049","volume":"9","author":"W Rhoades","year":"2015","unstructured":"Rhoades, W., Dickson, D. & Do, D. V. Potential role of lampalizumab for treatment of geographic atrophy. Clin. Ophthalmol. 9, 1049\u20131056 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"11262_CR8","unstructured":"http:\/\/investors.apellis.com\/news-releases\/news-release-details\/apellis-pharmaceuticals-announces-18-month-results-phase-2-study."},{"key":"11262_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0974-9233.173134","volume":"23","author":"I Taskintuna","year":"2016","unstructured":"Taskintuna, I., Elsayed, M. E. & Schatz, P. Update on clinical trials in dry age-related macular degeneration. Middle East Afr. J. Ophthalmol. 23, 13\u201326 (2016).","journal-title":"Middle East Afr. J. Ophthalmol."},{"key":"11262_CR10","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1167\/iovs.14-14802","volume":"55","author":"T Ach","year":"2014","unstructured":"Ach, T. et al. Quantitative autofluorescence and cell density maps of the human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 55, 4832\u20134841 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR11","doi-asserted-by":"publisher","first-page":"e001","DOI":"10.1017\/S0952523815000310","volume":"33","author":"AC Starnes","year":"2016","unstructured":"Starnes, A. C. et al. Multi-nucleate retinal pigment epithelium cells of the human macula exhibit a characteristic and highly specific distribution. Vis. Neurosci. 33, e001 (2016).","journal-title":"Vis. Neurosci."},{"key":"11262_CR12","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1136\/bjo.60.5.324","volume":"60","author":"SH Sarks","year":"1976","unstructured":"Sarks, S. H. Ageing and degeneration in the macular region: a clinico-pathological study. Br. J. Ophthalmol. 60, 324\u2013341 (1976).","journal-title":"Br. J. Ophthalmol."},{"key":"11262_CR13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0002-9440(10)63836-9","volume":"162","author":"G Malek","year":"2003","unstructured":"Malek, G., Li, C. M., Guidry, C., Medeiros, N. E. & Curcio, C. A. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am. J. Pathol. 162, 413\u2013425 (2003).","journal-title":"Am. J. Pathol."},{"key":"11262_CR14","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1167\/iovs.10-6476","volume":"52","author":"RF Mullins","year":"2011","unstructured":"Mullins, R. F., Johnson, M. N., Faidley, E. A., Skeie, J. M. & Huang, J. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 52, 1606\u20131612 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ajo.2011.08.012","volume":"153","author":"MY Lee","year":"2012","unstructured":"Lee, M. Y., Yoon, J. & Ham, D. I. Clinical characteristics of reticular pseudodrusen in Korean patients. Am. J. Ophthalmol. 153, 530\u2013535 (2012).","journal-title":"Am. J. Ophthalmol."},{"key":"11262_CR16","first-page":"436","volume":"37","author":"A Khaliq","year":"1996","unstructured":"Khaliq, A., Jarvis-Evans, J., McLeod, D. & Boulton, M. Oxygen modulates the response of the retinal pigment epithelium to basic fibroblast growth factor and epidermal growth factor by receptor regulation. Invest. Ophthalmol. Vis. Sci. 37, 436\u2013443 (1996).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0161-6420(00)00580-7","volume":"108","author":"W Smith","year":"2001","unstructured":"Smith, W. et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108, 697\u2013704 (2001).","journal-title":"Ophthalmology"},{"key":"11262_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/archopht.1995.01100060069034","volume":"113","author":"JA Mares-Perlman","year":"1995","unstructured":"Mares-Perlman, J. A. et al. Dietary fat and age-related maculopathy. Arch. Ophthalmol. 113, 743\u2013748 (1995).","journal-title":"Arch. Ophthalmol."},{"key":"11262_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ajcn\/86.1.180","volume":"86","author":"CJ Chiu","year":"2007","unstructured":"Chiu, C. J., Milton, R. C., Gensler, G. & Taylor, A. Association between dietary glycemic index and age-related macular degeneration in nondiabetic participants in the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 86, 180\u2013188 (2007).","journal-title":"Am. J. Clin. Nutr."},{"key":"11262_CR20","doi-asserted-by":"publisher","first-page":"e53155","DOI":"10.1371\/journal.pone.0053155","volume":"8","author":"JP SanGiovanni","year":"2013","unstructured":"SanGiovanni, J. P. et al. DNA sequence variants in PPARGC1A, a gene encoding a coactivator of the omega-3 LCPUFA sensing PPAR-RXR transcription complex, are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways. PLoS ONE 8, e53155 (2013).","journal-title":"PLoS ONE"},{"key":"11262_CR21","doi-asserted-by":"publisher","first-page":"e5508","DOI":"10.1371\/journal.pone.0005508","volume":"4","author":"JP SanGiovanni","year":"2009","unstructured":"SanGiovanni, J. P. et al. Mitochondrial DNA variants of respiratory complex I that uniquely characterize haplogroup T2 are associated with increased risk of age-related macular degeneration. PLoS ONE 4, e5508 (2009).","journal-title":"PLoS One"},{"key":"11262_CR22","doi-asserted-by":"publisher","first-page":"e2091","DOI":"10.1371\/journal.pone.0002091","volume":"3","author":"JA Canter","year":"2008","unstructured":"Canter, J. A. et al. Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration. PLoS ONE 3, e2091 (2008).","journal-title":"PLoS One"},{"key":"11262_CR23","first-page":"265","volume":"42","author":"CA Curcio","year":"2001","unstructured":"Curcio, C. A., Millican, C. L., Bailey, T. & Kruth, H. S. Accumulation of cholesterol with age in human Bruch\u2019s membrane. Invest Ophthalmol. Vis. Sci. 42, 265\u2013274 (2001).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"11262_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche, L. G. et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat. Genet. 48, 134\u2013143 (2016).","journal-title":"Nat. Genet"},{"key":"11262_CR25","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1073\/pnas.0912019107","volume":"107","author":"BM Neale","year":"2010","unstructured":"Neale, B. M. et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc. Natl Acad. Sci. USA 107, 7395\u20137400 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR26","doi-asserted-by":"publisher","first-page":"7401","DOI":"10.1073\/pnas.0912702107","volume":"107","author":"W Chen","year":"2010","unstructured":"Chen, W. et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc. Natl Acad. Sci. USA 107, 7401\u20137406 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR27","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/hmg\/ddi204","volume":"14","author":"YP Conley","year":"2005","unstructured":"Conley, Y. P. et al. Candidate gene analysis suggests a role for fatty acid biosynthesis and regulation of the complement system in the etiology of age-related maculopathy. Hum. Mol. Genet. 14, 1991\u20132002 (2005).","journal-title":"Hum. Mol. Genet"},{"key":"11262_CR28","first-page":"1319","volume":"12","author":"N Tserentsoodol","year":"2006","unstructured":"Tserentsoodol, N. et al. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12, 1319\u20131333 (2006).","journal-title":"Mol. Vis."},{"key":"11262_CR29","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.1167\/iovs.14-15195","volume":"55","author":"M Fujihara","year":"2014","unstructured":"Fujihara, M., Cano, M. & Handa, J. T. Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental system. Invest. Ophthalmol. Vis. Sci. 55, 7285\u20137295 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR30","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ajpath.2011.04.010","volume":"179","author":"M Cano","year":"2011","unstructured":"Cano, M., Fijalkowski, N., Kondo, N., Dike, S. & Handa, J. Advanced glycation endproduct changes to Bruch\u2019s membrane promotes lipoprotein retention by lipoprotein lipase. Am. J. Pathol. 179, 850\u2013859 (2011).","journal-title":"Am. J. Pathol."},{"key":"11262_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1111\/j.1471-4159.2008.05211.x","volume":"105","author":"Y Yamada","year":"2008","unstructured":"Yamada, Y. et al. Oxidized low density lipoproteins induce a pathologic response by retinal pigmented epithelial cells. J. Neurochem. 105, 1187\u20131197 (2008).","journal-title":"J. Neurochem."},{"key":"11262_CR32","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1073\/pnas.1413347112","volume":"112","author":"RB Thompson","year":"2015","unstructured":"Thompson, R. B. et al. Identification of hydroxyapatite spherules provides new insight into subretinal pigment epithelial deposit formation in the aging eye. Proc. Natl Acad. Sci. USA 112, 1565\u20131570 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.preteyeres.2014.03.002","volume":"41","author":"IA Pikuleva","year":"2014","unstructured":"Pikuleva, I. A. & Curcio, C. A. Cholesterol in the retina: the best is yet to come. Prog. Retin. Eye Res. 41, 64\u201389 (2014).","journal-title":"Prog. Retin. Eye Res."},{"key":"11262_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.exer.2008.07.010","volume":"87","author":"M Rudolf","year":"2008","unstructured":"Rudolf, M. et al. Sub-retinal drusenoid deposits in human retina: organization and composition. Exp. Eye Res. 87, 402\u2013408 (2008).","journal-title":"Exp. Eye Res."},{"key":"11262_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/path.4128","volume":"229","author":"KB Ebrahimi","year":"2012","unstructured":"Ebrahimi, K. B., Fijalkowski, N., Cano, M. & Handa, J. T. Decreased membrane complement regulators in the retinal pigmented epithelium contributes to age-related macular degeneration. J. Pathol. 229, 729\u2013742 (2012).","journal-title":"J. Pathol."},{"key":"11262_CR36","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.ophtha.2016.02.009","volume":"123","author":"U Greferath","year":"2016","unstructured":"Greferath, U., Guymer, R. H., Vessey, K. A., Brassington, K. & Fletcher, E. L. Correlation of histologic features with in vivo imaging of reticular pseudodrusen. Ophthalmology 123, 1320\u20131331 (2016).","journal-title":"Ophthalmology"},{"key":"11262_CR37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/bjophthalmol-2015-308290","volume":"100","author":"IA Bhutto","year":"2016","unstructured":"Bhutto, I. A. et al. Increased choroidal mast cells and their degranulation in age-related macular degeneration. Br. J. Ophthalmol. 100, 720\u2013726 (2016).","journal-title":"Br. J. Ophthalmol."},{"key":"11262_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1159\/000446587","volume":"236","author":"S Camelo","year":"2016","unstructured":"Camelo, S., Lavelette, S., Guillonneau, X., Raoul, W. & Sennlaub, F. Association of choroidal interleukin-17-producing T lymphocytes and macrophages with geographic atrophy. Ophthalmologica 236, 53\u201358 (2016).","journal-title":"Ophthalmologica"},{"key":"11262_CR39","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjo.2009.165563","volume":"94","author":"S Cherepanoff","year":"2010","unstructured":"Cherepanoff, S., McMenamin, P., Gillies, M. C., Kettle, E. & Sarks, S. H. Bruch\u2019s membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br. J. Ophthalmol. 94, 918\u2013925 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"11262_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17634-1","volume":"8","author":"C Kosmidou","year":"2018","unstructured":"Kosmidou, C. et al. Issues with the specificity of immunological reagents for NLRP3: implications for age-related macular degeneration. Sci. Rep. 8, 461 (2018).","journal-title":"Sci. Rep."},{"key":"11262_CR41","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/path.4816","volume":"241","author":"S Theodoropoulou","year":"2017","unstructured":"Theodoropoulou, S. et al. Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. J. Pathol. 241, 45\u201356 (2017).","journal-title":"J. Pathol."},{"key":"11262_CR42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2012.03.036","volume":"149","author":"V Tarallo","year":"2012","unstructured":"Tarallo, V. et al. DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell 149, 847\u2013859 (2012).","journal-title":"Cell"},{"key":"11262_CR43","doi-asserted-by":"publisher","first-page":"E3040","DOI":"10.1073\/pnas.1424391112","volume":"112","author":"CB Toomey","year":"2015","unstructured":"Toomey, C. B., Kelly, U., Saban, D. R. & Bowes Rickman, C. Regulation of age-related macular degeneration-like pathology by complement factor H. Proc. Natl Acad. Sci. USA 112, E3040\u2013E3049 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR44","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature10449","volume":"478","author":"D Weismann","year":"2011","unstructured":"Weismann, D. et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478, 76\u201381 (2011).","journal-title":"Nature"},{"key":"11262_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep22889","volume":"6","author":"B Molins","year":"2016","unstructured":"Molins, B. et al. Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants. Sci. Rep. 6, 22889 (2016).","journal-title":"Sci. Rep."},{"key":"11262_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neurobiolaging.2005.05.012","volume":"27","author":"J Feher","year":"2006","unstructured":"Feher, J. et al. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 27, 983\u2013993 (2006).","journal-title":"Neurobiol. Aging"},{"key":"11262_CR47","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.1167\/iovs.10-5429","volume":"51","author":"PP Karunadharma","year":"2010","unstructured":"Karunadharma, P. P., Nordgaard, C. L., Olsen, T. W. & Ferrington, D. A. Mitochondrial DNA damage as a potential mechanism for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 51, 5470\u20135479 (2010).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR48","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1167\/iovs.07-1352","volume":"49","author":"CL Nordgaard","year":"2008","unstructured":"Nordgaard, C. L., Karunadharma, P. P., Feng, X., Olsen, T. W. & Ferrington, D. A. Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 49, 2848\u20132855 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR49","doi-asserted-by":"publisher","first-page":"7304","DOI":"10.1523\/JNEUROSCI.0190-15.2015","volume":"35","author":"MR Terluk","year":"2015","unstructured":"Terluk, M. R. et al. Investigating mitochondria as a target for treating age-related macular degeneration. J. Neurosci. 35, 7304\u20137311 (2015).","journal-title":"J. Neurosci."},{"key":"11262_CR50","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/978-3-319-17121-0_106","volume":"854","author":"B Rohrer","year":"2016","unstructured":"Rohrer, B., Bandyopadhyay, M. & Beeson, C. Reduced metabolic capacity in aged primary retinal pigment epithelium (RPE) is correlated with increased susceptibility to oxidative stress. Adv. Exp. Med. Biol. 854, 793\u2013798 (2016).","journal-title":"Adv. Exp. Med. Biol."},{"key":"11262_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-4419-1399-9_20","volume":"664","author":"Y He","year":"2010","unstructured":"He, Y. & Tombran-Tink, J. Mitochondrial decay and impairment of antioxidant defenses in aging RPE cells. Adv. Exp. Med. Biol. 664, 165\u2013183 (2010).","journal-title":"Adv. Exp. Med. Biol."},{"key":"11262_CR52","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/tera.1420070306","volume":"7","author":"JU Schweichel","year":"1973","unstructured":"Schweichel, J. U. & Merker, H. J. The morphology of various types of cell death in prenatal tissues. Teratology 7, 253\u2013266 (1973).","journal-title":"Teratology"},{"key":"11262_CR53","doi-asserted-by":"publisher","first-page":"21695","DOI":"10.1073\/pnas.1009179107","volume":"107","author":"G Trichonas","year":"2010","unstructured":"Trichonas, G. et al. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc. Natl Acad. Sci. USA 107, 21695\u201321700 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR54","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/cdd.2013.109","volume":"21","author":"Y Murakami","year":"2014","unstructured":"Murakami, Y. et al. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ. 21, 270\u2013277 (2014).","journal-title":"Cell Death Differ."},{"key":"11262_CR55","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0002-9394(99)80146-9","volume":"125","author":"EH Souied","year":"1998","unstructured":"Souied, E. H. et al. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am. J. Ophthalmol. 125, 353\u2013359 (1998).","journal-title":"Am. J. Ophthalmol."},{"key":"11262_CR56","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1086\/301901","volume":"63","author":"CC Klaver","year":"1998","unstructured":"Klaver, C. C. et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am. J. Hum. Genet. 63, 200\u2013206 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"11262_CR57","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archopht.116.8.1082","volume":"116","author":"ML Klein","year":"1998","unstructured":"Klein, M. L. et al. Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. Arch. Ophthalmol. 116, 1082\u20131088 (1998).","journal-title":"Arch. Ophthalmol."},{"issue":"5720","key":"11262_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"R. J. Klein","year":"2005","unstructured":"Klein, R. J., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308, 385\u2013389 (2005).","journal-title":"Science"},{"issue":"5720","key":"11262_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"J. L. Haines","year":"2005","unstructured":"Haines, J. L., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308, 419\u2013421 (2005).","journal-title":"Science"},{"key":"11262_CR60","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards, A. O. et al. Complement factor H polymorphism and age-related macular degeneration. Science 308, 421\u2013424 (2005).","journal-title":"Science"},{"key":"11262_CR61","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/hmg\/9.9.1329","volume":"9","author":"DE Weeks","year":"2000","unstructured":"Weeks, D. E. et al. A full genome scan for age-related maculopathy. Hum. Mol. Genet. 9, 1329\u20131349 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"11262_CR62","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/hmg\/ddi353","volume":"14","author":"A Rivera","year":"2005","unstructured":"Rivera, A. et al. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum. Mol. Genet. 14, 3227\u20133236 (2005).","journal-title":"Hum. Mol. Genet."},{"issue":"5801","key":"11262_CR63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1126\/science.1133807","volume":"314","author":"A. DeWan","year":"2006","unstructured":"Dewan, A., et al. HTRA1 Promoter polymorphism in wet age-related macular degeneration. Science 314, 989\u2013992 (2006).","journal-title":"Science"},{"key":"11262_CR64","doi-asserted-by":"crossref","unstructured":"Yang, Z., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314, 992\u2013993 (2006).","DOI":"10.1126\/science.1133811"},{"issue":"6","key":"11262_CR65","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1056\/NEJMoa072618","volume":"357","author":"John R.W. Yates","year":"2007","unstructured":"Yates, J. R., et al. Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357, 553\u2013561 (2007).","journal-title":"New England Journal of Medicine"},{"key":"11262_CR66","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ng2131","volume":"39","author":"JB Maller","year":"2007","unstructured":"Maller, J. B. et al. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 39, 1200\u20131201 (2007).","journal-title":"Nat. Genet."},{"key":"11262_CR67","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng1750","volume":"38","author":"B Gold","year":"2006","unstructured":"Gold, B. et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38, 458\u2013462 (2006).","journal-title":"Nat. Genet."},{"key":"11262_CR68","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.140","volume":"17","author":"JA Fagerness","year":"2009","unstructured":"Fagerness, J. A. et al. Variation near complement factor I is associated with risk of advanced AMD. Eur. J. Hum. Genet. 17, 100\u2013104 (2009).","journal-title":"Eur. J. Hum. Genet."},{"key":"11262_CR69","doi-asserted-by":"publisher","first-page":"e25775","DOI":"10.1371\/journal.pone.0025775","volume":"6","author":"G Jun","year":"2011","unstructured":"Jun, G. et al. Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS ONE 6, e25775 (2011).","journal-title":"PLoS One"},{"key":"11262_CR70","doi-asserted-by":"publisher","first-page":"1510.e1517","DOI":"10.1016\/j.neurobiolaging.2013.12.007","volume":"35","author":"MW Logue","year":"2014","unstructured":"Logue, M. W. et al. Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways. Neurobiol. Aging 35, 1510.e1517\u20131510.e1518 (2014).","journal-title":"Neurobiol. Aging"},{"key":"11262_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-015-0760-4","volume":"16","author":"JB Hall","year":"2015","unstructured":"Hall, J. B. et al. Estimating cumulative pathway effects on risk for age-related macular degeneration using mixed linear models. BMC Bioinformatics 16, 329 (2015).","journal-title":"BMC Bioinformatics"},{"key":"11262_CR72","doi-asserted-by":"publisher","first-page":"R246","DOI":"10.1093\/hmg\/ddx343","volume":"26","author":"MM DeAngelis","year":"2017","unstructured":"DeAngelis, M. M. et al. Genetics of age-related macular degeneration (AMD). Hum. Mol. Genet. 26, R246 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"11262_CR73","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.visres.2009.09.016","volume":"50","author":"AC Silveira","year":"2010","unstructured":"Silveira, A. C. et al. Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vis. Res. 50, 698\u2013715 (2010).","journal-title":"Vis. Res."},{"key":"11262_CR74","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/ddp472","volume":"19","author":"LA Hecker","year":"2010","unstructured":"Hecker, L. A. et al. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum. Mol. Genet. 19, 209\u2013215 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"11262_CR75","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1093\/hmg\/ddr270","volume":"20","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Common variants near FRK\/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum. Mol. Genet. 20, 3699\u20133709 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"11262_CR76","first-page":"439e431","volume":"45","author":"LG Fritsche","year":"2013","unstructured":"Fritsche, L. G. et al. Seven new loci associated with age-related macular degeneration. Nat. Genet. 45, 439e431\u2013432 (2013).","journal-title":"Nat. Genet."},{"key":"11262_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7063","volume":"6","author":"CY Cheng","year":"2015","unstructured":"Cheng, C. Y. et al. New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nat. Commun. 6, 6063 (2015).","journal-title":"Nat. Commun."},{"key":"11262_CR78","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1086\/503822","volume":"78","author":"S Schmidt","year":"2006","unstructured":"Schmidt, S. et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am. J. Hum. Genet. 78, 852\u2013864 (2006).","journal-title":"Am. J. Hum. Genet."},{"key":"11262_CR79","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000094141","volume":"61","author":"JM Seddon","year":"2006","unstructured":"Seddon, J. M., George, S., Rosner, B. & Klein, M. L. CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum. Hered. 61, 157\u2013165 (2006).","journal-title":"Hum. Hered."},{"key":"11262_CR80","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ng.2740","volume":"45","author":"H Helgason","year":"2013","unstructured":"Helgason, H. et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat. Genet. 45, 1371\u20131374 (2013).","journal-title":"Nat. Genet."},{"key":"11262_CR81","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon, J. M. et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 45, 1366\u20131370 (2013).","journal-title":"Nat. Genet."},{"key":"11262_CR82","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/ng.2640","volume":"45","author":"JP van de Ven","year":"2013","unstructured":"van de Ven, J. P. et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat. Genet. 45, 813\u2013817 (2013).","journal-title":"Nat. Genet."},{"key":"11262_CR83","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/ng.2758","volume":"45","author":"X Zhan","year":"2013","unstructured":"Zhan, X. et al. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat. Genet. 45, 1375\u20131379 (2013).","journal-title":"Nat. Genet."},{"key":"11262_CR84","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.ophtha.2018.03.040","volume":"125","author":"J Corominas","year":"2018","unstructured":"Corominas, J. et al. Whole-exome sequencing in age-related macular degeneration identifies rare variants in COL8A1, a component of Bruch\u2019s membrane. Ophthalmology 125, 1433\u20131443 (2018).","journal-title":"Ophthalmology"},{"key":"11262_CR85","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1167\/iovs.14-14246","volume":"55","author":"NA Restrepo","year":"2014","unstructured":"Restrepo, N. A. et al. Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study. Invest. Ophthalmol. Vis. Sci. 55, 6839\u20136850 (2014).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR86","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fgene.2015.00238","volume":"6","author":"MA Morrison","year":"2015","unstructured":"Morrison, M. A. et al. Ancestry of the Timorese: age-related macular degeneration associated genotype and allele sharing among human populations from throughout the world. Front. Genet. 6, 238 (2015).","journal-title":"Front. Genet."},{"key":"11262_CR87","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1167\/iovs.17-21734","volume":"58","author":"PJ Persad","year":"2017","unstructured":"Persad, P. J. et al. Joint analysis of nuclear and mitochondrial variants in age-related macular degeneration identifies novel loci TRPM1 and ABHD2\/RLBP1. Invest. Ophthalmol. Vis. Sci. 58, 4027\u20134038 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR88","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/15592294.2015.1060388","volume":"10","author":"VF Oliver","year":"2015","unstructured":"Oliver, V. F. et al. Differential DNA methylation identified in the blood and retina of AMD patients. Epigenetics 10, 698\u2013707 (2015).","journal-title":"Epigenetics"},{"key":"11262_CR89","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2011.04.029","volume":"118","author":"JM Seddon","year":"2011","unstructured":"Seddon, J. M., Reynolds, R., Shah, H. R. & Rosner, B. Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. Ophthalmology 118, 1386\u20131394 (2011).","journal-title":"Ophthalmology"},{"key":"11262_CR90","doi-asserted-by":"publisher","first-page":"a017210","DOI":"10.1101\/cshperspect.a017210","volume":"5","author":"DJ Morgan","year":"2014","unstructured":"Morgan, D. J. & DeAngelis, M. M. Differential gene expression in age-related macular degeneration. Cold Spring Harb. Perspect. Med. 5, a017210 (2014).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"11262_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03856-y","volume":"9","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. ATAC-Seq analysis reveals a widespread decrease of chromatin accessibility in age-related macular degeneration. Nat. Commun. 9, 1364 (2018).","journal-title":"Nat. Commun."},{"key":"11262_CR92","doi-asserted-by":"publisher","first-page":"E8214","DOI":"10.1073\/pnas.1710430114","volume":"114","author":"CA Galloway","year":"2017","unstructured":"Galloway, C. A. et al. Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc. Natl Acad. Sci. USA 114, E8214\u2013E8223 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR93","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stem.2016.12.015","volume":"20","author":"JS Saini","year":"2017","unstructured":"Saini, J. S. et al. Nicotinamide ameliorates disease phenotypes in a human iPSC model of age-related macular degeneration. Cell Stem Cell 20, 635\u2013647 e637 (2017).","journal-title":"Cell Stem Cell"},{"key":"11262_CR94","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3390\/molecules14093446","volume":"14","author":"K Maiese","year":"2009","unstructured":"Maiese, K., Chong, Z. Z., Hou, J. & Shang, Y. C. The vitamin nicotinamide: translating nutrition into clinical care. Molecules 14, 3446\u20133485 (2009).","journal-title":"Molecules"},{"key":"11262_CR95","doi-asserted-by":"publisher","first-page":"92","DOI":"10.21037\/sci.2017.10.07","volume":"4","author":"LA Farrer","year":"2017","unstructured":"Farrer, L. A. & DeAngelis, M. M. Human induced pluripotent stem cells illuminate pathways and novel treatment targets for age-related macular degeneration. Stem Cell Invest. 4, 92 (2017).","journal-title":"Stem Cell Invest."},{"key":"11262_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5047","volume":"5","author":"X Zhong","year":"2014","unstructured":"Zhong, X. et al. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs. Nat. Commun. 5, 4047 (2014).","journal-title":"Nat. Commun."},{"key":"11262_CR97","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ceb.2012.10.004","volume":"24","author":"S Mahmoudi","year":"2012","unstructured":"Mahmoudi, S. & Brunet, A. Aging and reprogramming: a two-way street. Curr. Opin. Cell Biol. 24, 744\u2013756 (2012).","journal-title":"Curr. Opin. Cell Biol."},{"key":"11262_CR98","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.exer.2009.01.017","volume":"88","author":"M Fujihara","year":"2009","unstructured":"Fujihara, M., Bartels, E., Nielsen, L. B. & Handa, J. T. A human apoB100 transgenic mouse expresses human apoB100 in the RPE and develops features of early AMD. Exp. Eye Res. 88, 1115\u20131123 (2009).","journal-title":"Exp. Eye Res"},{"key":"11262_CR99","doi-asserted-by":"publisher","first-page":"E4472","DOI":"10.1073\/pnas.1702302114","volume":"114","author":"S Rowan","year":"2017","unstructured":"Rowan, S. et al. Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc. Natl Acad. Sci. USA 114, E4472\u2013E4481 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR100","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm1709","volume":"14","author":"JG Hollyfield","year":"2008","unstructured":"Hollyfield, J. G. et al. Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat. Med. 14, 194\u2013198 (2008).","journal-title":"Nat. Med."},{"key":"11262_CR101","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature09830","volume":"471","author":"H Kaneko","year":"2011","unstructured":"Kaneko, H. et al. DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature 471, 325\u2013330 (2011).","journal-title":"Nature"},{"key":"11262_CR102","doi-asserted-by":"publisher","first-page":"11900","DOI":"10.1073\/pnas.0503015102","volume":"102","author":"G Malek","year":"2005","unstructured":"Malek, G. et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc. Natl Acad. Sci. USA 102, 11900\u201311905 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11262_CR103","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1167\/iovs.14-14453","volume":"55","author":"M Nakayama","year":"2014","unstructured":"Nakayama, M. et al. Overexpression of HtrA1 and exposure to mainstream cigarette smoke leads to choroidal neovascularization and subretinal deposits in aged mice. Invest Ophthalmol. Vis. Sci. 55, 6514\u20136523 (2014).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"11262_CR104","doi-asserted-by":"publisher","first-page":"BIO121","DOI":"10.1167\/iovs.17-21764","volume":"58","author":"M Pfau","year":"2017","unstructured":"Pfau, M. et al. Green-light autofluorescence versus combined blue-light autofluorescence and near-infrared reflectance imaging in geographic atrophy secondary to age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 58, BIO121\u2013BIO130 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR105","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1016\/j.ophtha.2013.05.029","volume":"120","author":"Y Ouyang","year":"2013","unstructured":"Ouyang, Y., Heussen, F. M., Hariri, A., Keane, P. A. & Sadda, S. R. Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology 120, 2656\u20132665 (2013).","journal-title":"Ophthalmology"},{"key":"11262_CR106","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ophtha.2013.09.002","volume":"121","author":"DM Schwartz","year":"2014","unstructured":"Schwartz, D. M. et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology 121, 180\u2013187 (2014).","journal-title":"Ophthalmology"},{"key":"11262_CR107","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","volume":"125","author":"SR Sadda","year":"2018","unstructured":"Sadda, S. R. et al. Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3. Ophthalmology 125, 537\u2013548 (2018).","journal-title":"Ophthalmology"},{"key":"11262_CR108","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1364\/OE.8.000631","volume":"8","author":"H Hofer","year":"2001","unstructured":"Hofer, H. et al. Improvement in retinal image quality with dynamic correction of the eye\u2019s aberrations. Opt. Express 8, 631\u2013643 (2001).","journal-title":"Opt. Express"},{"key":"11262_CR109","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1364\/JOSAA.24.001468","volume":"24","author":"AE Elsner","year":"2007","unstructured":"Elsner, A. E., Weber, A., Cheney, M. C., VanNasdale, D. A. & Miura, M. Imaging polarimetry in patients with neovascular age-related macular degeneration. J. Opt. Soc. Am. A Opt. Image Sci. Vis. 24, 1468\u20131480 (2007).","journal-title":"J. Opt. Soc. Am. A Opt. Image Sci. Vis."},{"key":"11262_CR110","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.preteyeres.2017.06.005","volume":"60","author":"C Dysli","year":"2017","unstructured":"Dysli, C. et al. Fluorescence lifetime imaging ophthalmoscopy. Prog. Retin Eye Res. 60, 120\u2013143 (2017).","journal-title":"Prog. Retin Eye Res."},{"key":"11262_CR111","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/lsm.22070","volume":"44","author":"A Boretsky","year":"2012","unstructured":"Boretsky, A. et al. In vivo imaging of photoreceptor disruption associated with age-related macular degeneration: a pilot study. Lasers Surg. Med. 44, 603\u2013610 (2012).","journal-title":"Lasers Surg. Med."},{"key":"11262_CR112","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1364\/BOE.2.001864","volume":"2","author":"A Dubra","year":"2011","unstructured":"Dubra, A. et al. Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed. Opt. Express 2, 1864\u20131876 (2011).","journal-title":"Biomed. Opt. Express"},{"key":"11262_CR113","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-genom-090413-025610","volume":"15","author":"LG Fritsche","year":"2014","unstructured":"Fritsche, L. G. et al. Age-related macular degeneration: genetics and biology coming together. Annu Rev. Genom. Hum. Genet. 15, 151\u2013171 (2014).","journal-title":"Annu Rev. Genom. Hum. Genet"},{"key":"11262_CR114","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-4614-0631-0_9","volume":"723","author":"E Kortvely","year":"2012","unstructured":"Kortvely, E. & Ueffing, M. Common mechanisms for separate maculopathies? Adv. Exp. Med. Biol. 723, 61\u201366 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"11262_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/srep40826","volume":"7","author":"MS Zinkernagel","year":"2017","unstructured":"Zinkernagel, M. S. et al. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci. Rep. 7, 40826 (2017).","journal-title":"Sci. Rep."},{"key":"11262_CR116","doi-asserted-by":"publisher","first-page":"BIO141","DOI":"10.1167\/iovs.17-21789","volume":"58","author":"H Bogunovic","year":"2017","unstructured":"Bogunovic, H. et al. Machine learning of the progression of intermediate age-related macular degeneration based on OCT imaging. Invest. Ophthalmol. Vis. Sci. 58, BIO141\u2013BIO150 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"11262_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2371-3","volume":"19","author":"SE Bouhaddani","year":"2018","unstructured":"Bouhaddani, S. E. et al. Integrating omics datasets with the OmicsPLS package. BMC Bioinformatics 19, 371 (2018).","journal-title":"BMC Bioinformatics"},{"key":"11262_CR118","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1089\/omi.2018.0097","volume":"22","author":"D Grapov","year":"2018","unstructured":"Grapov, D., Fahrmann, J., Wanichthanarak, K. & Khoomrung, S. Rise of deep learning for genomic, proteomic, and metabolomic data integration in precision medicine. OMICS 22, 630\u2013636 (2018).","journal-title":"OMICS"},{"key":"11262_CR119","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exer.2018.01.009","volume":"168","author":"G Budak","year":"2018","unstructured":"Budak, G., Dash, S., Srivastava, R., Lachke, S. A. & Janga, S. C. Express: a database of transcriptome profiles encompassing known and novel transcripts across multiple development stages in eye tissues. Exp. Eye Res. 168, 57\u201368 (2018).","journal-title":"Exp. Eye Res."},{"key":"11262_CR120","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nrc4015","volume":"15","author":"AA Friedman","year":"2015","unstructured":"Friedman, A. A., Letai, A., Fisher, D. E. & Flaherty, K. T. Precision medicine for cancer with next-generation functional diagnostics. Nat. Rev. Cancer 15, 747\u2013756 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"11262_CR121","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/nyas.13588","volume":"1411","author":"J Merino","year":"2018","unstructured":"Merino, J. & Florez, J. C. Precision medicine in diabetes: an opportunity for clinical translation. Ann. NY Acad. Sci. 1411, 140\u2013152 (2018).","journal-title":"Ann. NY Acad. Sci."},{"key":"11262_CR122","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaophthalmol.2015.5492","volume":"134","author":"AM Williams","year":"2016","unstructured":"Williams, A. M., Stamer, W. D. & Allingham, R. R. Increasing the availability and quality of donor eyes for research. JAMA Ophthalmol. 134, 351\u2013352 (2016).","journal-title":"JAMA Ophthalmol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11262-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11262-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:26:16Z","timestamp":1671218776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11262-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":122,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["11262"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-11262-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"assertion":[{"value":"31 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.T.H.: Grant funding from Bayer Pharmaceuticals, Inc. J.W.M.: Consultant\/Advisor for Genentech\/Roche, Bausch+Lomb, Kalvista Pharmaceuticals, ONL Therapeutics; Grant Support from Lowy Medical Research Institute; Equity in ONL Therapeutics; Patents\/Royalties from ONL Therapeutics\/Mass. Eye and Ear, Valeant Pharmaceuticals\/Mass. Eye and Ear. C.A.T.: Alcon royalties for surgical technologies. M.Z.: Cell Cure, Chengdu Kanghong Biotech, Coherus Biosciences, Daiichi Sankyo, Frequency Therapeutics, Healios KK, Iridex, Isarna Therapeutics, Genentech\/Roche, Makindus, Novartis Pharma AG, Ophthotech, Percept Corp., Rutgers University (patent). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3347"}}